Status:
COMPLETED
Impact of Vitamin D Repletion in Hemodialysis Patients
Lead Sponsor:
Mehrotra, Anita, M.D.
Collaborating Sponsors:
National Kidney Foundation, United States
American Heart Association
Conditions:
Vitamin D Deficiency
End-stage Renal Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Dialysis patients often suffer from defects in their immune system (that part of the body which fights infection). Evidence suggests that Vitamin D deficiency may have a negative effect on immunity, a...
Detailed Description
Innate and adaptive immunity are commonly impaired in patients with end stage renal disease (ESRD) on dialysis. The myriad of immune defects in these patients, often attributed to uremia, may account ...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Chronic hemodialysis treatments for at least 2 consecutive months
- 25OH-Vitamin D level \< 25 ng/mL (inclusion criteria for randomization)
Exclusion
- History of acute renal failure requiring dialysis with potential for renal recovery
- History of HIV/AIDS
- Inability to provide informed consent
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT01175798
Start Date
August 1 2010
End Date
August 1 2013
Last Update
September 22 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai School of Medicine
New York, New York, United States, 10029